The 7th Cell Therapy Analytical Development Summit 2025
Returning for its 7th edition, the Cell Therapy Analytical Development Summit featured two new focused tracks to tailor your learning by development stage, and enhance cross-functional collaborations.
The Early-Stage Analytical Development Track explored designing multi-assay potency matrices, advanced cellular kinetics, and future-proofing strategies for preclinical and Phase 1 programs. The Late-Stage Analytical Development Track covered transitioning assays to fully validated methods, managing late-stage changes through comparability planning, and leveraging clinical data to build robust potency and release assays for commercial readiness.
What Set Us Apart in 2025?
Five Tangible Benefits You Walked Away with
Supercharge your knowledge of novel tools to enhance predictive modeling and decode mechanism of action (MoA) from the start. Refine and validate your potency assays in later stages following learnings from Avobis Bio, Genentech, and Cellectis
Gain hands-on experience in designing GMP- and IVD-ready flow cytometry assays with SuperNova FlowCytometry to enhance your capabilities, meet stringent regulatory requirements and earn three CMLE credits
Optimize your sterility and microbial testing workflows by understanding US Pharmacopoeia’s new chapters and rapid test validation approaches, through insights from the National Institute of Health, BioNTech, Vertex Pharmaceuticals, and the University of Calgary
Streamline complex assay transfer and tech transfer processes with case studies from Quell Therapeutics and Dana Farber Cancer Institute, for faster validation, reduced transfer-related variability, and smoother commercial scale-up
Accelerate your understanding of current regulatory guidelines and updates by hearing from key opinion leaders at Bristol Myers Squibb, Cellectis and the National Institute of Standards & Technology
Connect with cell therapy experts working across analytical development, quality control and CMC to gain practical insights and tackle challenges from early-stage assay design through to late-stage validation and regulatory readiness
2025 Full Event Guide
- 25+ industry-leading speakers from top pharma, biotech and academia
- 2 dedicated tracks of content, spanning each phase of cell therapy development
- An ASCP/ACP and CMLE-accredited workshop
- Real-world expertise from recent FDA leadership and regulatory bodies
Attending Companies Included
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of cell therapy deals.
Join Cell Therapy Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of analytical development and make critical connections during our dedicated networking sessions.